The success of a COVID-19 vaccine depends on effective scientific communication
One commonality amongst all reporting associated with the COVID-19 pandemic: “unprecedented.” Unprecedented circumstances, unprecedented symptomatology, unprecedented prevalence, and now, unprecedented velocity. “300 million doses of a safe, effective vaccine for COVID-19 by January 2021”—the project: Operation Warp Speed.
On January 20, 2020, the first case of COVID-19 was reported in the United States; fast forward to July 2020 and the National Institutes of Health …